NCT06759727 is a clinical trial in Small Bowel Gangrene, sponsored by Assiut University.

Who is sponsoring NCT06759727?

NCT06759727 is sponsored by Assiut University.

What condition does NCT06759727 study?

NCT06759727 studies Small Bowel Gangrene, Mesenteric Artery Ischemia, Strangulated Hernia.

Is NCT06759727 still recruiting?

NCT06759727 is currently not yet recruiting. Last updated 7 January 2025.

Last reviewed 2025-01-07 · How we verify

NCT06759727

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcomes of Different Surgical Procedures After High Level Resection for Patients With Small Intestinal Gangrene

Not yet recruiting Last updated 7 January 2025

What this trial tests

trial in Small Bowel Gangrene in 40 participants. Not yet recruiting.

Timeline

1 January 2025

Primary endpoint
1 September 2026

1 October 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 January 2025
Primary completion	1 September 2026
Estimated completion	1 October 2026

Conditions studied

Small Bowel Gangrene — all drugs for Small Bowel Gangrene →
Mesenteric Artery Ischemia — all drugs for Mesenteric Artery Ischemia →
Strangulated Hernia — all drugs for Strangulated Hernia →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Small Bowel Gangrene or Mesenteric Artery Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this cohort study, aim to evaluate and compare short-term postoperative outcomes of different surgical procedures for patients with intestinal gangrene who underwent high level small bowel resection (\< 150 cm from DJ).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06759727 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 7 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06759727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing